Drug Eluting Stent Market in China - Industry Research Report 2015-2019
About drug eluting stent
Drug eluting stent, also known as medicated coronary stent, is a tiny, expandable metal mesh tube that is covered with a pharmacologic agent. It prevents artery blockages in patients after angioplasty. It also eliminates the need for repeated revascularization procedures that are used to treat restenosis (narrowing of blood vessels).
Technavio's analysts forecast the drug eluting stent market in China to grow at a CAGR of 10.70% over the period 2014-2019.
Covered in this report
This report covers the present and future scenario of the drug eluting stent market in China for the period 2015-2019. To calculate the market size, Technavio uses revenue generated from the sales of drug eluting stents.
Technavio's report, Drug Eluting Stent Market in China 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the drug eluting stent market in China and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.Key vendors
Technavio Announces the Publication of its Research Report – Drug Eluting Stent Market in China 2015-2019
Technavio recognizes the following companies as the key players in the Drug Eluting Stent Market in China: MicroPort Scientific, Lepu Medical, Shandong JW Medical Systems, Abbott Vascular and Medtronic
Other Prominent Vendors in the market are: Boston Scientific, Biosensors International, Cook Medical, Opto Circuit, QualiMed, Sinomed, and Terumo Medical.
Commenting on the report, an analyst from Technavio’s team said: “There is a growing demand for invasive procedures among the elderly population with cardiovascular diseases worldwide, which is propelling the growth of drug-eluting stent market in China. Also, cost efficiencies offered by minimally invasive methods are likely to increase the demand for the procedures shortly. These procedures are performed through small incisions in the body, and can be used to treat plaque blockages in the arteries of the heart and other vessel walls of peripheral organs such as kidneys and brain.”
According to the report, increased workload, physical inactivity, and unhealthy diet lead to high blood glucose, blood pressure, and accumulation of lipids that cause hypertension, obesity, abnormal cholesterol, and diabetic problems in individuals. These factors result in cardiac disorders, which is also prevalent among the elderly aged 65 and above. In the recent years, incidences of CVDs such as stroke, myocardial infarction, and CHDs have increased.
Further, the report states that the preference for drugs over stents creates a major hindrance to the drug-eluting stent market in China.
MicroPort Scientific, Lepu Medical, Shandong JW Medical Systems, Abbott Vascular, Medtronic, Boston Scientific, Biosensors International, Cook Medical, Opto Circuit, QualiMed, Sinomed, Terumo Medical.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook